Olive Healthcare is a contract manufacturer based in India. It appears in 168 regulatory filings across 13 regulators, without an active US DMF or CEP on file. Its filings concentrate with FDA (GH), ZAMRA (ZM) and NAFDAC (NG). Its GMP standing is certified by NAFDAC (NG) and MCAZ (ZW). Its most recent recorded inspection, by US FDA, closed on 31 March 2017 as VAI. Customs aggregates show $5.5M of exports covering 93 molecules to 19 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Zhengzhou, United Arab Emirates | Not on file |
| Unit Ii, India | 3009681646 |
| Daman U.T Diu, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| FDA (GH) | 54 | None |
| ZAMRA (ZM) | 52 | None |
| NAFDAC (NG) | 22 | 2 |
| MPA (SE) | 11 | None |
| MINSA (CR) | 6 | None |
| DIGEMAPS (DO) | 6 | None |
| MCAZ (ZW) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $5.5M | 19 |
| 2024 | Not reported | $25.3M | 24 |
| 2023 | Not reported | $21.8M | 24 |
| 2022 | Not reported | $21.5M | 23 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Olive Healthcare comes back tiered against every other supplier able to file there.
Start for free